0
Skip to Content
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data
BLOODPAC Portal
BLOODPAC Data Commons
Impact
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Events
Resources
BLOODPAC Governance
Insights
Videos
MEMBER LOGIN
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data
BLOODPAC Portal
BLOODPAC Data Commons
Impact
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Events
Resources
BLOODPAC Governance
Insights
Videos
MEMBER LOGIN
Folder: About
Folder: Approach
Folder: Data
Folder: Impact
BLOODPAC Events
Folder: Resources
MEMBER LOGIN
Back
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Back
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Back
BLOODPAC Portal
BLOODPAC Data Commons
Back
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
Back
BLOODPAC Governance
Insights
Videos
Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons
Cheyenne Jankiewicz April 23, 2025 Cheyenne Jankiewicz April 23, 2025

Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons

Read More
Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-based Tests for Early Cancer Detection
Cheyenne Jankiewicz April 21, 2025 Cheyenne Jankiewicz April 21, 2025

Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-based Tests for Early Cancer Detection

Read More

ABOUT

BLOODPAC is a consortium managed by the Center for Computational Science Research, Inc. (CCSR), which is an Illinois based 501 (c)(3) not-for-profit corporation. Our mission is to accelerate the development, validation, and accessibility of liquid biopsy assays to improve outcomes for patients with cancer. To do so, we lead a pre-competitive collaborative infrastructure that enables the sharing of information and building of consensus among stakeholders in industry, academia, regulatory bodies, payers, and government agencies.